- Open Access
Digital health in musculoskeletal care: where are we heading?
BMC Musculoskeletal Disorders volume 24, Article number: 192 (2023)
BMC Musculoskeletal Disorders launched a Collection on digital health to get a sense of where the wind is blowing, and what impact these technologies are and will have on musculoskeletal medicine. This editorial summarizes findings and focuses on some key topics, which are valuable as digital health establishes itself in patient care. Elements discussed are digital tools for the diagnosis, prognosis and evaluation of rheumatic and musculoskeletal diseases, coupled together with advances in methodologies to analyse health records and imaging. Moreover, the acceptability and validity of these digital advances is discussed. In sum, this editorial and the papers presented in this article collection on Digital health in musculoskeletal care will give the interested reader both a glance towards which future we are heading, and which new challenges these advances bring.
Rheumatic and musculoskeletal diseases (RMDs) negatively impact the lives of many, while incurring an outsized economic impact on those working in society. Current treatment strategies improve clinical outcomes but are often labour intensive and patients` demands are high. Moreover, the ratio of patients to health professionals are increasing in many countries, indicating intense pressure on the healthcare system to deliver optimal care . Additionally, options for self-management strategies for patients with RMDs is beyond reach in most understaffed clinics. Digital health may represent a solution for some of these challenges in RMD clinical practice.
Digital health is thus one of the advancing frontiers in musculoskeletal care, which BMC Musculoskeletal Disorders set about highlighting when we launched this article collection. The technological spectrum is ever expanding, with regular advances being tested and incorporated into healthcare systems to create efficient care while aiming for the optimal outcome for every patient with. Read within this collection for some exciting research highlights, as the COVID-19 pandemic ushered in an era of remote healthcare [2,3,4] with telemedicine becoming the new norm [5, 6]. The mass uptake of wearables for routine living has expanded their use for preventive approaches [7, 8]. While the integration of digital solutions into healthcare systems is the inevitable future of musculoskeletal healthcare, data protection laws [9, 10] and formal testing [11, 12] has just begun to come to the fore.
This emerging field refers broadly to health services and information delivered or enhanced through digital technologies . A subpart of digital health, namely mobile health or in short mHealth, refers in general to medical and public health practice supported by mobile devices [14,15,16]. The past few years have seen exponential increases in mHealth applications, supported by the sudden need of remote care over the COVID-19 pandemic. While the field of mHealth has been limited initially to smartphone apps, the broad range of applications now available for both patients and physicians is on the way to revolutionizing the way we provide routine care. Most of the smartphone apps proposed initially in the literature of musculoskeletal health were focused and limited to the collection of patients reported outcomes , subsequently restricting their impact on direct patient care. In addition to their limited functionality, users - especially patients- would rapidly stop as no benefit was perceived on their health; according to a mixed methods study . Therefore, the acceptance of mHealth applications by the various stakeholders in the healthcare system is not always straight forward in clinical practice [19,20,21]. Use of digital tools to gather self-reported data for patient centered research outlining the patient experience is another emerging area of post pandemic research. An active involvement of patient support groups and patient research partners lends a unique flavor to meaningful patient driven research- for the patients and by the patients.
Luckily, the revolution in digital health goes further than just applications on smartphones [22, 23]. Perhaps the most advanced field in digital health is the development of analytical methods including machine learning and artificial intelligence (AI) [24,25,26]. The combination of data from electronic health records, biobanking and/or remote monitoring coupled to the implementation of new methodologies such as AI and gamification will be key for a new era in in daily clinical care for patients living with RMDs . Examples published in this Collection include the recent development of smartphone apps with an image analysis through AI technology to diagnose arthritis or grade structural damage severity on plain radiographs [11, 25]. In addition, apps are now delivering therapeutic interventions such as rehabilitation programs with online personalized coaching linked to connected devices [16, 28, 29]. Virtual -and augmented reality have also started to demonstrate feasibility in telerehabilitation, therapeutic education, self-management advice, and symptom management strategies in the near future for patients with RMDs , but we need more standardized methods to evaluate the new technology so that different researcher and physician can exchange data and validate their result . Augmented reality has also started to demonstrate to support surgeons in the operating room [31, 32]. Patient and physician education, and use of open datasets including bibliometrics and altmetrics to track social engagement are other key facets of digital health. The evolving spectrum of cloud-based health approaches offers seamless opportunities to unify global healthcare.
Reliability and validity
One of the core tenets of robust science is that it is accomplished through validating original findings. Only then can a model become reproducible, generalizable and potentially translated into clinical practice . Prediction tools that often require validation the most, but are not often completed, include prognostic models, trial interventions, nomograms, decision trees, risk scores and web applications.
Original research is characterised by specific conditions (e.g. hospital, patient population), and a tool’s performance is generally suboptimal in a new cohort compared to the population it was developed on . Thus, validation assumes an important role in establishing accuracy of new tools, i.e. testing in another context to see if the original prediction and findings reproduce to a satisfactory level. Validation comes in many forms - from internal that makes use of the original data, to temporal which probes new patients in the same cohort at a later timepoint. The most rigorous and therefore most trustworthy is independent validation, say an external cohort in a different country or disease group. Only then can one verify the widespread usefulness of said approach and recommend its implementation into clinical practice .
In this Digital health in musculoskeletal care article collection, as expected in an emerging field, some technologies are still in the initial piloting phase. These include the “BackRx, a personalized mobile phone application for discogenic chronic low back pain”  and remote sample of biomarkers of inflammation in patients with RMDs . Independent validation is typically not required at this early stage and more about determining feasibility and safety. Some others aimed to achieve internal validation by determining the intra-class correlation coefficients, intra- and/or inter-observer reliability of their digital applications [12, 14, 15, 22, 37]. Others facilitated generalizability by incorporating a multi-centre prospective study design to assess their artificial intelligence and smartphone app interventions, respectively [11, 26]. Another even utilized temporal validation, when a new online program during orthopedic trauma surgery outpatient clinics was verified in a late cohort after the consultation was established .
Other articles in this collection did not include validation methods, and future digital health studies are strongly encouraged to validate the original findings. Compliance improves the impact of one’s research, and guidelines like REMARK (Reporting Recommendations for Tumor Marker Prognostic Studies) have introduced mandates for independent validation in the other research field .
To conclude, many digital health technologies have advanced over past years with the potential to impact positively patient care in a near future. Mobile health applications, and integrative analyses by machine learning or artificial intelligence seem to be the precursors that will enable rheumatic and musculoskeletal health care providers to deliver health interventions in a patient-tailored way. These techniques and practices need to be complemented by informative and evaluation processes to prevent an increase in health professionals work burden; and similarly, to avoid overwhelming staff with alerts from digital applications instigated by artificial intelligence.
We live in a time of Big Data coming from various sources such as electronic healthcare records, mHealth applications, biobank and -omics data. Likewise, methodologies such as artificial intelligence enable analysis and provide hope for continuous optimization of clinical care. However, many challenges still lay ahead before many of the digital health solutions currently used in research will make their way into practice.
While diligent patient care assumes the forefront, a wider application of creative solutions for research and education are important collaterals in the digital evolution. This collection offers a glimpse into the break of dawn in digital RMD evolution.
Rheumatic and musculoskeletal diseases
Battafarano DF, Ditmyer M, Bolster MB, Fitzgerald JD, Deal C, Bass AR, et al. 2015 American College of Rheumatology Workforce Study: supply and demand projections of adult rheumatology workforce, 2015–2030. Arthritis Care Res (Hoboken). 2018;70(4):617–26.
Gilbert AW, Booth G, Betts T, Goldberg A. A mixed-methods survey to explore issues with virtual consultations for musculoskeletal care during the COVID-19 pandemic. BMC Musculoskelet Disord. 2021;22(1):245.
Hepp P, Osterhoff G, Melcher P, Henkelmann R, Theopold J. Online consultation in an orthopedic trauma surgery outpatient clinic: is there a learning curve? BMC Musculoskelet Disord. 2022;23(1):196.
Estel K, Richter L, Weber G, Fellmer F, Mardian S, Willy C, et al. The use of video consultations to support orthopedic patients’ treatment at the interface of a clinic and general practitioners. BMC Musculoskelet Disord. 2022;23(1):968.
Costa F, Janela D, Molinos M, Lains J, Francisco GE, Bento V, et al. Telerehabilitation of acute musculoskeletal multi-disorders: prospective, single-arm, interventional study. BMC Musculoskelet Disord. 2022;23(1):29.
Hasani F, Malliaras P, Haines T, Munteanu SE, White J, Ridgway J, et al. Telehealth sounds a bit challenging, but it has potential: participant and physiotherapist experiences of gym-based exercise intervention for Achilles tendinopathy monitored via telehealth. BMC Musculoskelet Disord. 2021;22(1):138.
Ostlind E, Eek F, Stigmar K, Sant’Anna A, Hansson EE. Promoting work ability with a wearable activity tracker in working age individuals with hip and/or knee osteoarthritis: a randomized controlled trial. BMC Musculoskelet Disord. 2022;23(1):112.
Saito Y, Ishida T, Kataoka Y, Takeda R, Tadano S, Suzuki T, et al. Evaluation of gait characteristics in subjects with locomotive syndrome using wearable gait sensors. BMC Musculoskelet Disord. 2022;23(1):457.
Beukenhorst AL, Druce KL, De Cock D. Smartphones for musculoskeletal research - hype or hope? Lessons from a decennium of mHealth studies. BMC Musculoskelet Disord. 2022;23(1):487.
Kataria S, Ravindran V. Musculoskeletal care - at the confluence of data science, sensors, engineering, and computation. BMC Musculoskelet Disord. 2022;23(1):169.
Reed M, Rampono B, Turner W, Harsanyi A, Lim A, Paramalingam S, et al. A multicentre validation study of a smartphone application to screen hand arthritis. BMC Musculoskelet Disord. 2022;23(1):433.
Zhang P, Zhang RX, Chen XS, Zhou XY, Raithel E, Cui JL, et al. Clinical validation of the use of prototype software for automatic cartilage segmentation to quantify knee cartilage in volunteers. BMC Musculoskelet Disord. 2022;23(1):19.
Song K, Zhu S, Xiang X, Wang L, Xie S, Liu H, et al. An evidence-based tailored eHealth patient education tool for patients with knee osteoarthritis: protocol for a randomized controlled trial. BMC Musculoskelet Disord. 2022;23(1):274.
Beausejour M, Aubin D, Fortin C, N’Dongo Sangare M, Carignan M, Roy-Beaudry M, et al. Parents can reliably and accurately detect trunk asymmetry using an inclinometer smartphone app. BMC Musculoskelet Disord. 2022;23(1):752.
Mollard E, Pedro S, Schumacher R, Michaud K. Smartphone-based behavioral monitoring and patient-reported outcomes in adults with rheumatic and musculoskeletal disease. BMC Musculoskelet Disord. 2022;23(1):566.
Vad VB, Madrazo-Ibarra A, Estrin D, Pollak JP, Carroll KM, Vojta D, et al. Back Rx, a personalized mobile phone application for discogenic chronic low back pain: a prospective pilot study. BMC Musculoskelet Disord. 2022;23(1):923.
Najm A, Gossec L, Weill C, Benoist D, Berenbaum F, Nikiphorou E. Mobile Health apps for self-management of Rheumatic and Musculoskeletal Diseases: systematic literature review. JMIR Mhealth Uhealth. 2019;7(11):e14730.
Najm A, Lempp H, Gossec L, Berenbaum F, Nikiphorou E, Needs. Experiences, and views of people with Rheumatic and Musculoskeletal Diseases on Self-Management Mobile Health apps: mixed methods study. JMIR Mhealth Uhealth. 2020;8(4):e14351.
Doumen M, Westhovens R, Pazmino S, Bertrand D, Stouten V, Neys C, et al. The ideal mhealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups. BMC Musculoskelet Disord. 2021;22(1):746.
Paskins Z, Bullock L, Manning F, Bishop S, Campbell P, Cottrell E, et al. Acceptability of, and preferences for, remote consulting during COVID-19 among older patients with two common long-term musculoskeletal conditions: findings from three qualitative studies and recommendations for practice. BMC Musculoskelet Disord. 2022;23(1):312.
Stern BZ, Pila S, Joseph LI, Rothrock NE, Franklin PD. Patients’ perspectives on the benefits of feedback on patient-reported outcome measures in a web-based personalized decision report for hip and knee osteoarthritis. BMC Musculoskelet Disord. 2022;23(1):806.
Fan J, Gu F, Lv L, Zhang Z, Zhu C, Qi J, et al. Reliability of a human pose tracking algorithm for measuring upper limb joints: comparison with photography-based goniometry. BMC Musculoskelet Disord. 2022;23(1):877.
Kristoffersson E, Otten V, Crnalic S. The accuracy of digital templating in cementless total hip arthroplasty in dysplastic hips. BMC Musculoskelet Disord. 2021;22(1):942.
Esfandiari H, Troxler P, Hodel S, Suter D, Farshad M, Collaboration G, et al. Introducing a brain-computer interface to facilitate intraoperative medical imaging control - a feasibility study. BMC Musculoskelet Disord. 2022;23(1):701.
Olsson S, Akbarian E, Lind A, Razavian AS, Gordon M. Automating classification of osteoarthritis according to Kellgren-Lawrence in the knee using deep learning in an unfiltered adult population. BMC Musculoskelet Disord. 2021;22(1):844.
Sato Y, Takegami Y, Asamoto T, Ono Y, Hidetoshi T, Goto R, et al. Artificial intelligence improves the accuracy of residents in the diagnosis of hip fractures: a multicenter study. BMC Musculoskelet Disord. 2021;22(1):407.
De Cock D, Myasoedova E, Aletaha D, Studenic P. Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs). Ther Adv Musculoskelet Dis. 2022;14:1759720X221105978.
Wang G, Yang M, Hong M, Krauss J, Bailey JF. Clinical outcomes one year after a digital musculoskeletal (MSK) program: an observational, longitudinal study with nonparticipant comparison group. BMC Musculoskelet Disord. 2022;23(1):237.
Wang L, Xie S, Bao T, Zhu S, Liang Q, Wang X, et al. Exercise and education for community-dwelling older participants with knee osteoarthritis: a video-linked programme protocol based on a randomised controlled trial. BMC Musculoskelet Disord. 2021;22(1):470.
Ebrahimi N, Rojhani-Shirazi Z, Yoosefinejad AK, Nami M. The effects of virtual reality training on clinical indices and brain mapping of women with patellofemoral pain: a randomized clinical trial. BMC Musculoskelet Disord. 2021;22(1):900.
Dennler C, Bauer DE, Scheibler AG, Spirig J, Gotschi T, Furnstahl P, et al. Augmented reality in the operating room: a clinical feasibility study. BMC Musculoskelet Disord. 2021;22(1):451.
Kiani S, Rezaei I, Abasi S, Zakerabasali S, Yazdani A. Technical aspects of virtual augmented reality-based rehabilitation systems for musculoskeletal disorders of the lower limbs: a systematic review. BMC Musculoskelet Disord. 2023;24(1):4.
Ramspek CL, Jager KJ, Dekker FW, Zoccali C, van Diepen M. External validation of prognostic models: what, why, how, when and where? Clin Kidney J. 2021;14(1):49–58.
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med. 2015;13:1.
Siontis GC, Tzoulaki I, Castaldi PJ, Ioannidis JP. External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination. J Clin Epidemiol. 2015;68(1):25–34.
Druce KL, Gibson DS, McEleney K, Yimer BB, Meleck S, James B, et al. Remote sampling of biomarkers of inflammation with linked patient generated health data in patients with rheumatic and musculoskeletal diseases: an ecological momentary Assessment feasibility study. BMC Musculoskelet Disord. 2022;23(1):770.
Huang T, Wang L, Lu C, Zhong W, Zhao Z, Luo X. A novel rapid measurement of hallux valgus parameters using the built-in photo edit function of smartphones. BMC Musculoskelet Disord. 2021;22(1):716.
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst. 2005;97(16):1180–4.
Ethics approval and consent to participate
Consent for publication
All authors declare no competing interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Gupta, L., Najm, A., Kabir, K. et al. Digital health in musculoskeletal care: where are we heading?. BMC Musculoskelet Disord 24, 192 (2023). https://doi.org/10.1186/s12891-023-06309-w
- Digital health
- Virtual consultation
- Artificial intelligence